[HTML][HTML] Clinical review: goal-directed therapy-what is the evidence in surgical patients? The effect on different risk groups

M Cecconi, C Corredor, N Arulkumaran, G Abuella… - Critical care, 2013 - Springer
Patients with limited cardiac reserve are less likely to survive and develop more complications
following major surgery. By augmenting oxygen delivery index (DO 2 I) with a combination …

A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases

N Arulkumaran, RJ Unwin, FWK Tam - Expert opinion on …, 2011 - Taylor & Francis
Introduction: The P2X7 receptor (P2X7R) has an important role in inflammation and immunity,
but until recently, clinical application has been limited by a lack of specific antagonists. …

[HTML][HTML] Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single …

…, Z Hrušková, L Holm, M Weiner, N Arulkumaran… - Kidney international, 2017 - Elsevier
Co-presentation with both ANCA and anti-GBM antibodies is thought to be relatively rare.
Current studies of such ‘double-positive’ cases report small numbers and variable outcomes. …

Mitochondrial function in sepsis

N Arulkumaran, CS Deutschman, MR Pinsky… - Shock, 2016 - journals.lww.com
Mitochondria are an essential part of the cellular infrastructure, being the primary site for
high-energy adenosine triphosphate production through oxidative phosphorylation. Clearly, in …

[HTML][HTML] Creating complex protocells and prototissues using simple DNA building blocks

N Arulkumaran, M Singer, S Howorka… - Nature …, 2023 - nature.com
Building synthetic protocells and prototissues hinges on the formation of biomimetic skeletal
frameworks. Recreating the complexity of cytoskeletal and exoskeletal fibers, with their …

Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study

N Arulkumaran, N Periselneris, G Gaskin… - …, 2011 - academic.oup.com
Objectives. ANCA-associated vasculitis and interstitial lung disease (ILD) are uncommon
conditions. The occurrence of both diseases in the same patient is increasingly recognized. …

[HTML][HTML] Tocilizumab in COVID-19: a meta-analysis, trial sequential analysis, and meta-regression of randomized-controlled trials

…, G Ambler, E Nastouli, M Singer, N Arulkumaran - Intensive Care …, 2021 - Springer
Purpose Interleukin-6 (IL-6) levels discriminate between patients with mild and severe
COVID-19, making IL-6 inhibition an attractive therapeutic strategy. We conducted a systematic …

[HTML][HTML] Use of non-invasive ventilation for patients with COVID-19: a cause for concern?

N Arulkumaran, D Brealey, D Howell… - The Lancet. Respiratory …, 2020 - ncbi.nlm.nih.gov
The potential for transmission of coronavirus disease 2019 (COVID-19) from patients to
health-care workers has caused concern, particularly among patients requiring advanced …

[HTML][HTML] Antimicrobial-associated harm in critical care: a narrative review

N Arulkumaran, M Routledge, S Schlebusch… - Intensive care …, 2020 - Springer
The belief that, for the individual patient, the benefit of prompt and continued use of antimicrobials
outweighs any potential harm is a significant barrier to improved stewardship of these …

Palliative care interventions in intensive care unit patients

…, D Anagnostou, S Vlachos, N Arulkumaran… - Intensive Care …, 2021 - Springer
Purpose The integration of palliative care into intensive care units (ICUs) is advocated to
mitigate physical and psychological burdens for patients and their families, and to improve end-…